Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis
Personalis’s liquid biopsy is a part of a rising marketplace for minimal residual illness assays, checks that search for any ...
Tag: 1.5B
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
France-based pharma firm Servier is buying the muscular dystrophy enterprise of Edgewise Therapeutics as a part of a income progress ...
Four Biotech IPOs Raise $1.5B in April, the Biggest Month in Five Years
Hemab Therapeutics and Seaport Therapeutics are the latest biotech firms to hitch the general public markets, every with an upsized ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!